使用多组分结构化炼来改善老年人的抑郁症:系统性审查和元分析
Shishi Cheng1, Yanping Duan1, Min Yang2
1Department of Sport, Physical Education and Health, Hong Kong Baptist University, Kowloon, Hong Kong, China.
Journal of exercise science and fitness
|February 10, 2025
概括
多组件结构化炼 (MSE) 显著降低了老年人的抑郁症. 最佳的结果取决于干预频率和参与者保留率,以有效地管理老年抑郁症.
科学领域:
- 老年学是指老年学的学科.
- 运动科学 运动科学
- 心理健康 心理健康
背景情况:
- 抑郁症是老年人普遍存在的问题,影响生活质量.
- 多组件结构化炼 (MSE) 是有前途的,但需要进一步评估有效性.
- 识别主持人可以优化对老年抑郁症的干预策略.
研究的目的:
- 评估MSE干预措施对老年人抑郁症的有效性.
- 确定影响MSE有效性的特征和调节者.
- 综合来自随机对照试验 (RCT) 的证据.
主要方法:
- 在多个数据库 (MEDLINE,PubMed,PsycINFO等) 中进行系统的文献搜索. 在2000年至2024年期间.
- 包括评估MSE (有氧,抵抗,平衡) 的RCT在老年人中,包括抑郁症结局.
- 随机效应的元分析和元回归来确定效应大小和调节者.
主要成果:
- 分析了19项研究 (1763名参与者),显示MSE对减少抑郁症有显著影响 (SMD, -0.49).
- 观察到相当大的异质性 (I2 = 92%),证据的确定性较低.
- 亚组分析表明,针对特定的参与者群体,干预持续时间 (12-24周),频率 (>2/周) 和保留率 (>80%) 的显著影响.
结论:
- 在老年人中,MSE有效改善抑郁症.
- 干预频率和保留率是MSE疗效的关键调节因素.
- 需要进一步的高质量的RCT来完善MSE策略,以预防和治疗老年人的抑郁症.
更多相关视频
07:40Validation of a Psychosocial Intervention on Body Image in Older People: An Experimental Design
Published on: May 31, 2021
3.2K
12:59Improving Strength, Power, Muscle Aerobic Capacity, and Glucose Tolerance through Short-term Progressive Strength Training Among Elderly People
Published on: July 5, 2017
12.5K
相关概念视频
Depression: Overview
208
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
208
Antidepressant Drugs: Overview
351
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
351
Depressive Disorders: MDD and Dysthymia
37
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
37
Antidepressant Drugs: MAOIs and Other Agents
183
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
183
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
285
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
285
Long-term Depression
30.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
30.5K
